Telbivudine (LdT)

DRUG3 trials

Sponsors

Novartis, Novartis Pharmaceuticals

Conditions

Chronic Hepatitis BHepatitis B

Phase 3

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

CompletedNCT00115245

NovartisChronic Hepatitis B

Start: 2004-11-30End: 2006-08-31Updated: 2015-05-12

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

CompletedNCT00142298

Novartis PharmaceuticalsChronic Hepatitis B

Start: 2005-03-31End: 2009-11-30Updated: 2020-08-21

Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)

TerminatedNCT00412750

NovartisHepatitis B

Start: 2006-12-31End: 2009-02-28Updated: 2011-07-13

Related Papers

Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B

Advances in Therapy2015-08-0122 citations

Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at week 24.

2012-12-135 citations